Tissue factor, the blood, and the arterial wall

Trends in Cardiovascular Medicine

Volumn 10, Issue 4, 2000, Pages 139-143

  Rauch, Ursula ^a   Nemerson, Yale ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Division of Thrombosis Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD15 ANTIGEN; FIBRIN; THROMBOPLASTIN;

ATHEROSCLEROTIC PLAQUE; BLOOD FLOW; BLOOD VESSEL INJURY; HUMAN; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOLOGY; LEUKOCYTE; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVIEW; SHEAR RATE; STENOSIS; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOGENESIS;

CORONARY CIRCULATION; CORONARY DISEASE; CORONARY VESSELS; HUMANS; THROMBOPLASTIN; THROMBOSIS;

EID: 0034470152     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(00)00049-9     Document Type: Review

References (50)

1. Maintenance of coronary patency after fibrinolysis with tissue factor pathway inhibitor
2. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome
3. Prevention of experimental arterial thrombosis by topical administration of active site-inactivated factor VIIa
4. Role of tissue factor in disseminated intravascular coagulation
5. Expression of tissue factor procoagulant activity; regulation by cytosolic calcium
6. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques; effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions
7. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor
8. Intimal hyperplasia after balloon injury is attenuated by blocking selectins
9. Disseminated intravascular coagulation; clinical and laboratory aspects
10. Cultured human endothelial cells generate tissue factor in response to endotoxin
11. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant
12. Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes
13. Exacerbation of cerebral injury in mice that express the P-selectin gene; identification of P-selectin blockade as a new target for the treatment of stroke
14. Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor
15. The unstable atherosclerotic plaque; clinical significance and therapeutic intervention
16. Coronary thrombosis
17. Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation
18. Blood-borne tissue factor; another view of thrombosis
19. Granulocytes enhance LPS-induced tissue factor activity in monocytes via an interaction with platelets
20. Antithrombotic strategies targeting thrombin activities, thrombin receptors and thrombin generation
21. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobunuria and aplastic anemia
22. x plays an important role in recurrent coronary arterial thrombosis in dogs
23. Cloning of GMP-140, an α-granule membrane protein of platelets and endothelium; sequence similarity to proteins involved in cell adhesion and inflammation
24. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease
25. Specific accumulation of circulating monocytes and polymorphonuclear leukocytes on platelet thrombi in a vascular injury model
26. Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model
27. PADGEM-dependent adhesion of platelets to monocytes and neutrophils is mediated by a lineage-specific carbohydrate, LNF III (CD15)
28. Procoagulant activity after exposure of monocyte-derived macrophages to minimally oxidized low density lipoprotein. Co-localization of tissue factor antigen and nascent fibrin fibers at the cell surface
29. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques; a role for apoptosis in plaque thrombogenicity
30. Association of tissue factor activity with the surface of cultured cells
31. Leukocyte trafficking mediated by selectin-carbohydrate interactions
32. Localization of tissue factor in actin-filament-rich membrane areas of epithelial cells
33. Tissue factor and hemostasis
34. Tissue factor; then and now
35. The stimulatory effect of platelets and platelet membranes on the procoagulant activity of leukocytes
36. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280
37. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets
38. Tissue thromboplastin activity of isolated human monocytes
39. Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro
40. Leukocytes transfer tissue factor to platelets during thrombosis
41. Tumor necrosis factor-induced endothelial tissue factor is associated with subendothelial matrix vesicles but is not expressed on the apical surface
42. Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation
43. Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina
44. Defects in hemostasis in P-selectin-deficient mice
45. Increased plasma tissue factor levels in acute myocardial infarction
46. Possible role of platelet-activating factor in the in vivo expression of tissue factor in neutrophils
47. Mechanisms that regulate the function of the selectins and their ligands
48. Tissue factor (thromboplastin); localization to plasma membranes by peroxidase-conjugated antibodies